Nivolumab
BMS
[]
today is the big day for endocrine and neuroendocrine neoplasms at #esmo22 very promising results of the #nicenec study perfectly presented by 
Medical Oncologist focused on GI & Endocrine Malignances. Vall Hebron University Hospital. Vall Hebron Institute of Oncology (VHIO). Teknon Cancer Institute.